NCT01869725 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 68
- units
- Participants
- groups
- description
- Patients receive gallium Ga 68-edotreotide IV and undergo PET/CT scan. Within 120 days, patients undergo standard indium In 111 pentetreotide contrast-enhanced CT or MRI scan. Patients may undergo a second gallium Ga 68-edotreotide PET/CT scan within 3-6 months if the lesions of the first scan cannot be confirmed. gallium Ga 68-edotreotide: Given IV positron emission tomography/computed tomography: Undergo gallium Ga 68-edotreotide PET/CT scan indium In 111 pentetreotide: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan computed tomography: Undergo indium In 111 pentetreotide contrast-enhanced CT scan contrast-enhanced magnetic resonance imaging: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan
- id
- BG000
- title
- Diagnostic (Gallium Ga 68-edotreotide PET/CT)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 45
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 18
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 4
- upper Limit
- 81
- value
- 55
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- title
- Female
- measurements
- group Id
- BG000
- value
- 35
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 28
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 38
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 68
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- eligible participants
- population Description
- 68 patients enrolled
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 68
- units
- Participants
- groups
- description
- Patients receive gallium Ga 68-edotreotide IV and undergo PET/CT scan. Within 120 days, patients undergo standard indium In 111 pentetreotide contrast-enhanced CT or MRI scan. Patients may undergo a second gallium Ga 68-edotreotide PET/CT scan within 3-6 months if the lesions of the first scan cannot be confirmed. gallium Ga 68-edotreotide: Given IV positron emission tomography/computed tomography: Undergo gallium Ga 68-edotreotide PET/CT scan indium In 111 pentetreotide: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan computed tomography: Undergo indium In 111 pentetreotide contrast-enhanced CT scan contrast-enhanced magnetic resonance imaging: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan
- id
- BG000
- title
- Diagnostic (Gallium Ga 68-edotreotide PET/CT)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 45
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 18
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 4
- upper Limit
- 81
- value
- 55
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- title
- Female
- measurements
- group Id
- BG000
- value
- 35
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 28
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 38
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 68
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- eligible participants
- population Description
- 68 patients enrolled
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle